Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8586714 Dual variable domain immunoglobulins and uses thereof

Patent 8586714 was granted and assigned to AbbVie Inc. on November, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 16 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12115191 Methods of treating age-related and inflammatory diseases
0
Edits on 4 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12077783 AAV-mediated delivery of antibodies to the inner ear
0
Edits on 3 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12024545 Methods of treating aging-related disorders
0
Edits on 27 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12018071 Single-chain chimeric polypeptides and uses thereof
0
Edits on 13 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12006366 Methods and compositions for preventing type 1 diabetes
0
Edits on 30 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11993660 Chimeric polypeptides and methods of altering the membrane localization of the same
0
Edits on 22 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11987619 Single-chain chimeric polypeptides and uses thereof
0
Edits on 1 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11884712 Multi-chain chimeric polypeptides and uses thereof
0
Edits on 12 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11697801 AAV-mediated delivery of therapeutic antibodies to the inner ear
0
Edits on 14 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11672826 Methods of treating aging-related disorders
0
Edits on 24 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08586714 Dual variable domain immunoglobulins and uses thereof US Patent 8586714 Dual variable domain immunoglobulins and uses thereof

Infobox
Patent Number
08586714
Patent Number
8586714
Edits on 21 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 21 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08586714 Dual variable domain immunoglobulins and uses thereof

Infobox
Is a
Patent
Patent
Current assignee
AbbVie Inc.
AbbVie Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08586714
Date of patent
November 19, 2013
Patent application number
12873926
Date Filed
September 1, 2010
Patent primary examiner
‌
Phuong Huynh

Find more entities like US Patent 8586714 Dual variable domain immunoglobulins and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.